// App-Quantinova.ai

: Thrombophilia Gene Mutations for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy

Researchers

Presenter

  • Danielle Carole Roy

Principal Investigators

  • Tzu-Fei Wang

  • Ranjeeta Mallick

  • Philip S. Wells

  • Marc Carrier

  • Steven Hawken

Medical Centers

  • Department of Medicine, University of Ottawa, Ottawa, Canada

  • School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada

  • The Ottawa Hospital Research Institute, Ottawa, Canada

  • Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Inherited thrombophilia

  • Venous thrombosis

  • Deep vein thrombosis

  • Solid malignancies

Biomarkers

  • Prothrombin

  • Fibrinogen

Drug/Treatment

  • Fibrinogen (IV)

  • apixaban

Outcome

  • N/A

Study Design

  • Randomized

  • Efficacy

  • Safety

  • Placebo Control

  • Double Blind/Blinded

  • Prospective

  • Controlled

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved